Assignee
NORTH AMERICAN VACCINE INC
US·8 granted patents·293 citations·filing 1992–1997
Top patents by PatentIndex Score
8 records- 0192US5439808AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1993·Granted Aug 8, 1995·97 cites·19 claims
- 0286US5425946AVaccines against group C Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1992·Granted Jun 20, 1995·73 cites·9 claims
- 0382US5879686AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted Mar 9, 1999·35 cites·14 claims
- 0481US6013267AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted Jan 11, 2000·31 cites·19 claims
- 0570US5866135AGroup A streptococcal polysaccharide immunogenic compositions and methodsNORTH AMERICAN VACCINE INC·Filed 1994·Granted Feb 2, 1999·32 cites·49 claims
- 0655US5747287AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted May 5, 1998·17 cites·13 claims
- 0747US6153406AMethod for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type BNORTH AMERICAN VACCINE INC·Filed 1993·Granted Nov 28, 2000·8 cites·41 claims
- 0824US6284884B1Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereofNORTH AMERICAN VACCINE INC·Filed 1995·Granted Sep 4, 2001·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when NORTH AMERICAN VACCINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →